FIELD: pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition for use in the treatment of prostate pathologies and includes a mixture consisting of an effective amount of Serenoa repens, bromelain, curcumin, zinc, lycopene and selenium, and pharmacologically acceptable or food processing excipients and/or additives.
EFFECT: new pharmaceutical composition has been described, which is useful in the treatment of disorders or diseases or pathologies associated with prostatitis and/or benign prostatic hyperplasia and/or resulting from those.
9 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION WITH QUERCETIN, LYCOPENE AND NARINGIN FOR PREVENTING CHRONIC PROSTATITIS - CHRONIC PELVIC PAIN SYNDROME | 2023 |
|
RU2835864C1 |
| REMEDY FOR THE PREVENTION AND TREATMENT OF PROSTATITIS AND BENIGN PROSTATE HYPERPLASIA | 2020 |
|
RU2751342C1 |
| COMBINATIONS OF EXTRACTS SERENOA REPENS AND LIPOPHILIC EXTRACTS ZINGIBER OFFICINALIS AND ECHINACEA ANGUSTIFOLIA, USE THEREOF AND COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2659153C2 |
| ANTIPROLIFERATIVE AGENT | 2011 |
|
RU2519727C2 |
| ANTIPROLIFERATIVE AGENT | 2012 |
|
RU2482857C1 |
| METHOD AND REMEDY FOR TREATMENT AND PREVENTION OF BENIGN PROSTATIC HYPERPLASIA | 2019 |
|
RU2764850C1 |
| MEDICATION (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CHEMOPROPHYLAXIS OF PROSTATE PRE-CANCER AND CANCER | 2012 |
|
RU2571818C2 |
| METHOD FOR PREVENTING AND TREATING BENIGN PROSTATIC HYPERPLASIA | 2014 |
|
RU2574014C2 |
| AGENT FOR PREVENTING AND TREATING PROSTATITIS AND PROSTATE ADENOMA | 2013 |
|
RU2538615C1 |
| MEANS FOR CORRECTING UROLOGIC ANDROLOGICAL PATHOLOGIES | 2004 |
|
RU2295336C2 |
